Aesica Expands Oral Solids Capability at German Facility - - BioPharm International

ADVERTISEMENT

Aesica Expands Oral Solids Capability at German Facility



Aesica Pharmaceuticals, a CDMO, is adding additional services in its oral solids capability including a new roller compaction unit for dry granulation production in Zwickau, Germany.

The new roller compaction unit uses a continuous production step that enhances product uniformity and has been undertaken following a market demand for pharmaceutical formulation technologies that enable the formulation of APIs otherwise inhibited by the presence of water.

Source: Aesica Pharmaceuticals

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

AbbVie/Shire Deal Officially Off
October 20, 2014
Amgen Sues Sanofi and Regeneron over Patent for mAb Targeting PCSK9
October 20, 2014
EMA Works to Speed Up Ebola Treatment
October 20, 2014
Lilly to Close Manufacturing Facility in Puerto Rico
October 17, 2014
BioReliance Introduces New Predictive Assays
October 17, 2014
Author Guidelines

Click here